Acetaminophen receipt among HIV-infected patients with advanced hepatic fibrosis

Pharmacoepidemiology and Drug Safety

Volumn 22, Issue 12, 2013, Pages 1352-1356

  Edelman, E Jennifer ^a,b   Gordon, Kirsha S ^c   Re, Vincent Lo ^d,e   Skanderson, Melissa ^c,f   Fiellin, David A ^a,b   Justice, Amy C ^a,b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Acetaminophen; Hepatitis C; HIV; Medication; Pharmacoepidemiology; Veterans

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; AZITHROMYCIN; CLARITHROMYCIN; DELAVIRDINE; FLUCONAZOLE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISONIAZID; ITRACONAZOLE; KETOCONAZOLE; NEVIRAPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; RIFABUTIN; RIFAMPICIN; TIPRANAVIR; VORICONAZOLE;

ADULT; ALCOHOL USE DISORDER; ARTICLE; CROSS-SECTIONAL STUDY; DRUG USE; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRESCRIPTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; THROMBOCYTE COUNT;

ACETAMINOPHEN; HEPATITIS C; HIV; MEDICATION; PHARMACOEPIDEMIOLOGY; VETERANS;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; CROSS-SECTIONAL STUDIES; DRUG PRESCRIPTIONS; DRUG UTILIZATION REVIEW; ELECTRONIC HEALTH RECORDS; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; INAPPROPRIATE PRESCRIBING; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 84888436621     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3517     Document Type: Article

References (19)

1. Bjornsson E, Olsson R. Suspected drug-induced liver fatalities reported to the WHO database. Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2006; 38(1): 33-38.
2. Myers RP, Shaheen AA, Li B, Dean S, Quan H. Impact of liver disease, alcohol abuse, and unintentional ingestions on the outcomes of acetaminophen overdose. Clin Gastroenterol Hepatol 2008; 6(8): 918-925.
3. Moling O, Cairon E, Rimenti G, Rizza F, Pristera R, Mian P. Severe hepatotoxicity after therapeutic doses of acetaminophen. Clin Ther 2006; 28(5): 755-760.
4. Nguyen GC, Sam J, Thuluvath PJ. Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: a nationwide analysis. Hepatology 2008; 48(4): 1336-1341.
5. Lederman JC, Nawaz H. Toxic interaction of didanosine and acetaminophen leading to severe hepatitis and pancreatitis: a case report and review of the literature. Am J Gastroenterol 2001; 96(12): 3474-3475.
6. Joshi D, O'Grady J, Dieterich D, Gazzard B, Agarwal K. Increasing burden of liver disease in patients with HIV infection. Lancet 2011; 377(9772): 1198-1209.
7. Wolf MS, King J, Jacobson K, et al. Risk of unintentional overdose with non-prescription acetaminophen products. J Gen Intern Med 2012; 27(12): 1587-1593.
8. Benzon HT, Kendall MC, Katz JA, et al. Prescription Patterns of Pain Medicine Physicians. Pain Pract 2013; 13(6): 440-450.
9. Clark R, Fisher JE, Sketris IS, Johnston GM. Population prevalence of high dose paracetamol in dispensed paracetamol/opioid prescription combinations: an observational study. BMC Clin Pharmacol 2012; 12: 11.
10. Mort JR, Shiyanbola OO, Ndehi LN, Xu Y, Stacy JN. Opioid-paracetamol prescription patterns and liver dysfunction: a retrospective cohort study in a population served by a US health benefits organization. Drug Saf 2011; 34(11): 1079-1088.
11. Albertson TE, Walker VM, Jr., Stebbins MR, Ashton EW, Owen KP, Sutter ME. A population study of the frequency of high-dose acetaminophen prescribing and dispensing. Ann Pharmacother 2010; 44(7-8): 1191-1195.
12. Fultz SL, Skanderson M, Mole LA, et al. Development and verification of a " virtual" cohort using the National VA Health Information System. Med Care 2006; 44(8 Suppl 2): S25-S30.
13. Steiner JF, Koepsell TD, Fihn SD, Inui TS. A general method of compliance assessment using centralized pharmacy records. Description and validation. Med Care 1988; 26(8): 814-823.
14. Edelman EJ, Gordon K, Becker WC, et al. Receipt of Opioid Analgesics by HIV-Infected and Uninfected Patients. J Gen Intern Med 2013; 28(1): 82-90.
15. Chandok N, Watt KD. Pain management in the cirrhotic patient: the clinical challenge. Mayo Clin Proc 2010; 85(5): 451-458.
16. Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006; 43(6): 1317-1325.
17. Hewitt DJ, McDonald M, Portenoy RK, Rosenfeld B, Passik S, Breitbart W. Pain syndromes and etiologies in ambulatory AIDS patients. Pain 1997; 70(2-3): 117-123.
18. Miaskowski C, Penko JM, Guzman D, Mattson JE, Bangsberg DR, Kushel MB. Occurrence and characteristics of chronic pain in a community-based cohort of indigent adults living with HIV infection. J Pain 2011; 12(9): 1004-1016.
19. Smith BD, Morgan RL, Beckett GA, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep 2012; 61(RR-4): 1-32.